Adnan A Kadi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Liquid Chromatography

Mass Spectrometry

Advanced Non Small Cell Lung Cancer

Top Venues

Molecules (Basel, Switzerland)

Drug design, development and therapy

Organic & biomolecular chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Aishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
Ion Trap LC/MS reveals the generation of reactive intermediates in acalabrutinib metabolism: phase I metabolic profiling and bioactivation pathways elucidation. RSC advances 14 (23) (2024)
Aishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
Ion Trap LC/MS reveals the generation of reactive intermediates in acalabrutinib metabolism: phase I metabolic profiling and bioactivation pathways elucidation. RSC advances 14 (23) (2024)
Aishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
Investigation of Fenebrutinib Metabolism and Bioactivation Using MS 3 Methodology in Ion Trap LC/MS. Molecules (Basel, Switzerland) 28 (10) (2023)
Mohamed W Attwa, Haitham AlRabiah, Adnan A Kadi
Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Adnan A Kadi
Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Ahmed H Bakheit, Adnan A Kadi
Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method. Molecules (Basel, Switzerland) 28 (6) (2023)
Mohamed W Attwa, Haitham AlRabiah, Adnan A Kadi
Development and Validation of a Rapid LC-MS/MS Method for Quantifying Alvocidib: In Silico and In Vitro Metabolic Stability Estimation in Human Liver Microsomes. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Ahmed H Bakheit, Adnan A Kadi
Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method. Molecules (Basel, Switzerland) 28 (6) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation. Molecules (Basel, Switzerland) 28 (5) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Ahmed H Bakheit, Adnan A Kadi
Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method. Molecules (Basel, Switzerland) 28 (6) (2023)
Mohamed W Attwa, Haitham AlRabiah, Gamal A E Mostafa, Adnan A Kadi
Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening. Pharmaceutics 15 (10) (2023)
Mohamed W Attwa, Ahmed H Bakheit, Ali Saber Abdelhameed, Adnan A Kadi
An Ultrafast UPLC-MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib. Molecules (Basel, Switzerland) 28 (20) (2023)
Mohamed W Attwa, Ali Saber Abdelhameed, Nawaf A Alsaif, Adnan A Kadi, Haitham AlRabiah
A validated LC-MS/MS analytical method for the quantification of pemigatinib: metabolic stability evaluation in human liver microsomes. RSC advances 12 (31) (2022)
Nasser S Al-Shakliah, Adnan A Kadi, Haya I Aljohar, Haitham AlRabiah, Mohamed W Attwa
Profiling of in vivo , in vitro and reactive zorifertinib metabolites using liquid chromatography ion trap mass spectrometry. RSC advances 12 (32) (2022)
Mohamed W Attwa, Hany W Darwish, Nasser S Al-Shakliah, Adnan A Kadi
A Validated LC-MS/MS Assay for the Simultaneous Quantification of the FDA-Approved Anticancer Mixture (Encorafenib and Binimetinib): Metabolic Stability Estimation. Molecules (Basel, Switzerland) 26 (9) (2021)
Chenghong Zhu, Tianzhang Kou, Adnan A Kadi, Jinbo Li, Yan Zhang
Molecular platforms based on biocompatible photoreactions for photomodulation of biological targets. Organic & biomolecular chemistry 19 (43) (2021)
Haitham AlRabiah, Adnan A Kadi, Haya I Aljohar, Mohamed W Attwa, Nasser S Al-Shakliah, Sabry M Attia, Gamal A E Mostafa
A New Validated HPLC-MS/MS Method for Quantification and Pharmacokinetic Evaluation of Dovitinib, a Multi-Kinase Inhibitor, in Mouse Plasma. Drug design, development and therapy 14 (2020)
Ali Saber Abdelhameed, Mohamed W Attwa, Adnan A Kadi
Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation. Molecules (Basel, Switzerland) 25 (21) (2020)
A F M Motiur Rahman, Wencui Yin, Adnan A Kadi, Yurngdong Jahng
Galeon: A Biologically Active Molecule with In Silico Metabolite Prediction, In Vitro Metabolic Profiling in Rat Liver Microsomes, and In Silico Binding Mechanisms with CYP450 Isoforms. Molecules (Basel, Switzerland) 25 (24) (2020)
Thamer A Alsubi, Mohamed W Attwa, Ahmed H Bakheit, Hany W Darwish, Hatem A Abuelizz, Adnan A Kadi
In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling. RSC advances 10 (38) (2020)